logo

For the Inventor, By the Inventor

Hanover, NH, United States of America

Ethan Dmitrovsky

This inventor holds 21 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent, primarily in Cancer Treatment. Top assignees: Dartmouth College, Io Therapeutics, Inc., Koebenhavns Universitet (University of Copenhagen). Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ethan Dmitrovsky. Retrieved from https://idiyas.com/inventor/ethan-dmitrovsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 66.7


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:

goldMedal17 out of 708 
 
Dartmouth College
 patents
silverMedal11 out of 72 
 
Io Therapeutics, Inc.
 patents
bronzeMedal1 out of 1 
 
Koebenhavns Universitet (University of Copenhagen)
 patent
4. 1 out of 3 
 
Lo Therapeutics, Inc.
 patents
5. 1 out of 133 
 
University of Copenhagen
 patents
where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
RXR Agonists
Autoimmune Disorders
Remyelination
MicroRNA Biomarkers
Breast Cancer
Lung Cancer
Fluorescence Lifetime Spectrometer
UBE1L Modulation
Oncogenic Protein Degradation
Transgenic Models
Diseased Tissue Detection
21 patents (USPTO):Explore Patents
1. 12383521 - Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists (2025-08-12),
2. 11793781 - Autoimmune disorder treatment using RXR agonists (2023-10-24),
3. 11576881 - Autoimmune disorder treatment using RXR agonists (2023-02-14),
4. 11547684 - Autoimmune disorder treatment using RXR agonists (2023-01-10),
5. 11246845 - Autoimmune disorder treatment using RXR agonists (2022-02-15),
6. 11166927 - Autoimmune disorder treatment using RXR agonists (2021-11-09),
7. 10945976 - Autoimmune disorder treatment using RXR agonists (2021-03-16),
8. 10695307 - Autoimmune disorder treatment using RXR agonists (2020-06-30),
9. 10653650 - Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists (2020-05-19),
10. 10285960 - Autoimmune disorder treatment using RXR agonists (2019-05-14),
11. 10201512 - Autoimmune disorder treatment using RXR agonists (2019-02-12),
12. 10034845 - Autoimmune disorder treatment using RXR agonists (2018-07-31),
13. 9056135 - MicroRNA biomarkers for human breast and lung cancer (2015-06-16),
14. 8697668 - Compositions and methods for preventing and treating cancer via modulating UBE1L, ISG215 and/or UBP43 (2014-04-15),
15. 8417324 - Fluorescence lifetime spectrometer (FLS) and methods of detecting diseased tissue (2013-04-09),

Title: The Innovative Journey of Inventor Ethan Dmitrovsky

Introduction: Ethan Dmitrovsky, a distinguished inventor based in Hanover, NH (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Ethan Dmitrovsky holds several patents in the medical field, focusing on novel treatments for cancer and other diseases. His recent patents include advancements in targeted therapies and precision medicine.

Career Highlights: With a background in oncology and molecular biology, Ethan Dmitrovsky has had a remarkable career trajectory. He has served as a leading researcher in renowned institutions, pioneering new approaches to personalized medicine.

Collaborations: Throughout his career, Ethan Dmitrovsky has collaborated with top pharmaceutical companies, research institutions, and universities worldwide. His partnerships have led to the development of cutting-edge technologies and life-saving treatments.

Conclusion: In conclusion, Ethan Dmitrovsky stands as a visionary inventor whose work continues to shape the landscape of medical innovations. His dedication to advancing healthcare through patents and inventions is truly commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…